5-MeO-AMT
| Clinical data | |
|---|---|
| Other names | 5-MeO-AMT; 5-Methoxy-α-methyltryptamine; α,O-Dimethylserotonin; α,O-DMS; Alpha-O |
| Routes of administration | Oral |
| Drug class | Serotonin receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Duration of action | 12–18 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H16N2O |
| Molar mass | 204.273 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 216 to 218 °C (421 to 424 °F) |
| |
| |
| (verify) | |
5-MeO-αMT, also known as 5-methoxy-α-methyltryptamine or as α,O-dimethylserotonin (α,O-DMS or Alpha-O), is a serotonergic psychedelic of the tryptamine, α-alkyltryptamine, and 5-methoxytryptamine families. It is a derivative of α-methyltryptamine (αMT) and an analogue of 5-MeO-DMT. The drug is said to be the most potent psychedelic of the simple indolealkylamines (i.e., tryptamines). It is active at oral doses of 2 to 4 mg.